Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group.

Lamy ML, Daily EK, Brichant JF, Larbuisson RP, Demeyere RH, Vandermeersch EA, Lehot JJ, Parsloe MR, Berridge JC, Sinclair CJ, Baron JF, Przybelski RJ.

Anesthesiology. 2000 Mar;92(3):646-56.

PMID:
10719942
2.

The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials.

Wang G, Bainbridge D, Martin J, Cheng D.

Anesth Analg. 2009 Aug;109(2):320-30. doi: 10.1213/ane.0b013e3181aa084c. Review.

PMID:
19608798
3.

Haemoglobin-based erythrocyte transfusion substitutes.

Standl T.

Expert Opin Biol Ther. 2001 Sep;1(5):831-43. Review.

PMID:
11728218
4.
5.

Blood substitutes. Haemoglobin therapeutics in clinical practice.

Baron JF.

Crit Care. 1999;3(5):R99-102. Epub 1999 Sep 28. Review.

6.

Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions.

Remy B, Deby-Dupont G, Lamy M.

Br Med Bull. 1999;55(1):277-98. Review.

PMID:
10695091
7.

The effects of perioperative blood transfusion on morbidity and mortality after esophagectomy.

Fields RC, Meyers BF.

Thorac Surg Clin. 2006 Feb;16(1):75-86. Review.

PMID:
16696285
8.
9.

Artificial blood: current status of hemoglobin solutions.

Gould SA, Sehgal LR, Sehgal HL, Moss GS.

Crit Care Clin. 1992 Apr;8(2):293-309. Review.

PMID:
1568141
10.

Hemoglobin-based oxygen carriers: development and clinical potential.

Ketcham EM, Cairns CB.

Ann Emerg Med. 1999 Mar;33(3):326-37. Review.

PMID:
10036348
11.

Reduction in requirements for allogeneic blood products: nonpharmacologic methods.

Hardy JF, Bélisle S, Janvier G, Samama M.

Ann Thorac Surg. 1996 Dec;62(6):1935-43. Review.

PMID:
8957437
12.

Hemoglobin substitutes.

Anbari KK, Garino JP, Mackenzie CF.

Eur Spine J. 2004 Oct;13 Suppl 1:S76-82. Epub 2004 May 27. Review.

13.

Hemorrhage and the use of blood products after adult cardiac operations: myths and realities.

Bélisle S, Hardy JF.

Ann Thorac Surg. 1996 Dec;62(6):1908-17. Review.

PMID:
8957433
14.

Risks of packed red blood cell transfusion in patients undergoing cardiac surgery.

Gerber DR.

J Crit Care. 2012 Dec;27(6):737.e1-9. doi: 10.1016/j.jcrc.2012.05.007. Epub 2012 Jul 2. Review.

PMID:
22762927
15.

Trends in exploitation of packed red blood cells.

Pristoupil TI, Fricova V, Kramlova M, Pristoupilova K, Vrana M, Ulrych S.

Biomater Artif Cells Artif Organs. 1988;16(1-3):141-7. Review.

PMID:
3052640
16.

Haemoglobin therapy in clinical practice: use and characteristics of DCLHb.

Baron JF.

Br J Anaesth. 1998 Dec;81 Suppl 1:34-7. Review. No abstract available.

PMID:
10318986
17.

[The value of blood transfusion in tumor surgery. Experiences from randomized trials].

Heiss MM.

Zentralbl Chir. 2000;125(10):842-6. Review. German.

PMID:
11098580
18.

Clinical development of human polymerized hemoglobin as a blood substitute.

Gould SA, Moss GS.

World J Surg. 1996 Nov-Dec;20(9):1200-7. Review.

PMID:
8864082
19.

[Red cell substitutes: perfluorocarbon emulsions and hemoglobin solutions].

Rémy B, Deby-Dupont G, D'Ans V, Ernest P, Lamy M.

Ann Fr Anesth Reanim. 1999 Feb;18(2):211-24. Review. French.

PMID:
10207594
20.

Effectiveness of intraoperative autologous whole blood and platelet-rich plasma in cardiac surgery.

Gravlee GP.

Ann Acad Med Singapore. 1994 Nov;23(6 Suppl):65-70. Review.

PMID:
7710239

Supplemental Content

Support Center